INVO Fertility Receives Nasdaq Delinquency Notice For Late 10-K And 10-Q Filings
INVO Fertility Q4 EPS $(40.40) Misses $(2.75) Estimate, Sales $1.583M Miss $1.927M Estimate
INVO Fertility Receives Nasdaq Noncompliance Notice, Gets 60 Calendar Days To Regain Compliance
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
INVO Fertility Announces 1-For-5 Reverse Stock Split, Effective March 27
INVO Fertility Adopts Time-Lapse Incubation Technology At Its Wisconsin Clinic
12 Health Care Stocks Moving In Tuesday's After-Market Session
INVO Fertility Secures U.S. Patent For Modified INVOcell Device, Extending IP Protection Through 2040
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
INVO Fertility Expects Combined Pro Forma Annualized Revenue Run Rate Of ~$9M
INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
Looking Into INVO Fertility Inc's Recent Short Interest
INVO Fertility Commences ~$7.5M Offering Of Outstanding Warrants At $1.59/Warrant
Why INVO Fertility (IVF) Stock Is Trending Overnight
This Little-Known Fertility Stock Is Up 215% in the Past 5 Days. Should You Chase the Mysterious Penny Stock Rally Here?
Watching Invitro Fertility Companies; Shares See Volume, Traders Circulate Unconfirmed Rumor President Trump Making Fertility Treatments Cheaper For Americans To Boost Birth Rates
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.